1. No sanctions for Novartis as FDA ends review of gene therapy violations— Medtronic makes plans for a ventilator open-source— COVID could cause 'digital reset' for pharma — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice


Discussion in 'Eurofins' started by anonymous, Feb 16, 2018 at 10:44 AM.

  1. anonymous

    anonymous Guest

    company out of Brussels. They have amassed a large qty of companies in numerous sectors. Many of these companies are worthless.